Withanolides (WTDs), well-known medicinally important compounds of Withania somnifera, including the anticancer compound withaferin A (WFA), are biosynthesized from their dedicated precursor squalene. Condensation of farnesyl pyrophosphate (FPP) molecules to produce squalene is catalyzed by squalene synthase (SQS). In the present study, the Arabidopsis thaliana squalene synthase gene (AtSQS1) was transformed in W. somnifera by Agrobacterium tumefaciens C58C1 (pRiA4). The AtSQS1 gene was detected in 87.88 % of induced transformed hairy roots (THRs). The results showed that the growth index (GI) of THRs after five weeks of culture was 2-fold higher than that of adventitious hairy roots (AHRs). The biomass doubling time of THRs and AHRs was 18 and 30 days, respectively. Quantitative evaluation of WFA in the studied roots showed that THRs contain 1.51-fold more WFA (330±0.87µg g -1 dry weight (DW)) than AHRs (218±0.17µg g -1 DW). These findings can be used for the production of WFA as a valuable anticancer compound through controlled and scaled up cultures of W. somnifera THRs.
Withania somnifera (L.) Dunal (Solanaceae) , is an herbaceous perennial plant, found in the drier parts of tropical zones from the Eastern Mediterranean region to Southwest Asia. Its robust chemotypical variability [1a,1b] and inconstant reproductive strategy of mixed mating enable it to grow under arid habitats with a broad geographic distribution [1c-1e] . W. somnifera (Ashwagandha), is a well-known medicinal plant, used in Ayurvedha for over 3,000 years [1f] . Traditionally, this plant has been applied to heal various physiological disorders and is attributed with a wide range of medicinal properties, acting as a sedative, energizer, rejuvenator, aphrodisiac and health enhancer [1g] . For instance, leaves and roots extracts are used in more than one hundred formulations in the Ayurveda, Siddha and Unani systems of medicine [2a,2b] , which are used for rescue from neurodegenerative and neuropsychiatric central nervous system disorders, as well as to facilitate cognition and slow down aging [2c] .
Literature surveys have revealed that W. somnifera produces a wide range of secondary metabolites including phytosterols, steroidal lactones, flavonoids, and alkaloids, which show an extensive spectrum of pharmacological activities [2d,2e] . These biological properties have been mainly attributed to a group of steroidal lactones called withanolides (WTDs). WTDs are based on an ergostane skeleton in which C-26 and C-22, or C-26 and C-23 are oxidized to form a δ or γ lactone and are synthesized via the triterpenoid pathway [1d,2a] . Although, the complicated metabolic steps of biochemical conversion of 24-methylene cholesterol into WTDs, involving desaturation, hydroxylation, epoxidation, cyclization, chain elongation and glycosylation, are yet not fully understood, the responsible genes in their biosynthesis have been partly specified by several researchers [3a-3d] . Squalene synthase (SQS) catalyzes the first step in phytosterol and triperpenoid biosynthesis, and it could play an important adjusting role in WTDs biosynthesis by acting at a crucial putative branch point. A general overview of the WTDs biosynthetic pathway is shown in Figure 1 . The ordinary major WTDs of W. somnifera are withaferin A (WFA), withanolide A (WNA), withanolide B (WNB), withanolide D (WND), and withanone (WNN) (Figure 2 ), which are mostly confined in the aerial parts and roots of the plant at a concentration generally ranging from 0.001 to 0.5% dry weight (DW) [2f,2g] . A review of the pharmacological properties of Withania constituents [1a] has highlighted the anticancer activity of WFA against prostate [4a,4b], breast [4c], leukemia [4d] , and melanoma cancer cells [5a] . The neuro-pharmacological properties of the other WTDs have also been reported [2a,5b] .
Owing to uncontrollable, illegal and indiscriminate wild harvesting of the plant for pharmaceutical purposes [5c], land-use disturbances, and irreparable reductions in the number of natural populations, W. somnifera has been categorized as a threatened species by the International Union for Conservation of Nature and Natural Resources (IUCN). The cultivation of the plant to provide WTDs for pharmaceutical use is also restricted by genetics, environmental conditions, the length of duration between sowing and harvesting of plant materials [5d,6a] ; as well as the quantitative variability of bioactive compounds. Moreover, these production methods are prolonged, labour-intensive and not able to meet the recent global market demand for the plant [6b] . Due to an ever-increasing demand for Ashwagandha and its therapeutically valuable compounds [6b], biotechnological progress and efficient techniques are needed to enhance yields in a faster production system. In vitro and metabolic engineering techniques are effective and substitute approaches for producing high-value bioactive molecules such as WTDs [6c]. In vitro culture techniques can be applied to produce hairy root (HR) cultures [6d,6e] and cell [6f] for WTDs production as well as mass propagation [6a,6b] . Since the W. somnifera roots contain a number of medicinally important WTDs, their mass culture in vitro could be an applicable technique for scale-up of this secondary metabolite. HR cultures are genetically produced by the transfer of genes located in the plasmid Ri (root inducing) of Gram negative soil bacterium Agrobacterium rhizogenes to plant host cells and their expression therein [6g, 6h] . These non-geotropic roots maintain a high growth rate, genetically and biochemically constant, usually producing high levels of secondary metabolites and can also be effectively cultured in largescale bioreactors, and have been successfully developed for the production of commercially important biomolecules in several medicinally important plants [7a,7b] [8a] showed an increase of both phytosterols and triterpenoids. According to Häkkinen et al., [8b] , SQS overexpression led to a 2.5-fold increase in WNA and WFA accumulation in the genetically transformed callus and cell suspension cultures of W. somnifera. In an earlier publication, we reported that WNA and WFA production, as well as phytosterols accumulation, significantly increased in a transgenic HR culture of W. coagulans carrying the AtSQS1 gene [6c]. Full-length SQS from W. somnifera (WsSQS; GenBank GU732820) with an open reading frame of 1242 bp has been previously cloned [3a] . Recently, Patel et al. [7g] showed that the overexpression of WsSQS leads to enhanced WTDs biosynthesis. Since genetically improved HRs of W. somnifera overexpressing the SQS gene have not been reported to date, we decided to use the SQS1 gene from A. thaliana [8c] . Two SQS-annotated genomic sequences comprising At4g34640 (AtSQS1) and At4g34650 (AtSQS2) are clarified in A. thaliana. The SQS1 gene can be widely expressed in all tissues throughout plant development, while SQS2 is mostly expressed in the vascular tissue of cotyledon, petioles, leaf and the hypocotyl of seedlings [8d] . In the present study, the AtSQS1 gene was used to improve the WFA content in transformed hairy roots (THRs) of W. somnifera for the first time. Our findings can be considered useful for the large-scale production of WFA as a valuable anticancer compound, as well as the other major WTDs and phytosterols in the controlled culture of W. somnifera THRs in industrial bioreactors.
Growth and morphology of hairy roots: Inoculated leaf explants of W. somnifera with A. tumefaciens strains C58C1 (pRiA4) or C58C1 (pRiA4) (pBIs SQS1) produced THRs after 15-20 days of culture. As can be seen in Table 1 , more than 90% of inoculated leaf segments developed roots, and the number of roots was 3-8 per explant four weeks after infection. Establishment of root line cultures was performed from picked off root tips appearing at the wounded sites of explants on hormone-free solid MS medium with four-week subculture intervals. THR cultures of the plant were preliminarly selected by culturing them in a medium fortified with kanamycin (50 mg L -1 ). A remarkable variation in growth capacity between the individual THR clones was also observed. For example, a selected THR carrying the AtSQS1 gene (line14, SQSL14) achieved 3.8-fold higher FW at the end of the growth period than the clone SQS L12. This variation is very frequent in transformed root cultures, since each clone arises from an independent transformation event as previously reported by Sevón et al. [7a] , Moyano et al. [8e, 9d] . Furthermore, A4 wild type HRs and THR lines showed a similar time course of growth and both of them achieved maximum FW at week five, corresponding to the end of the culture period. The doubling time of THR and AHR biomass was 18 and 30 days ( Figure 3 ). All the cultured HRs produced biomass levels similar to the AHRs. The increases in biomass accumulation were the result of integration of pRi T-DNA in the recipient HR genome through genetic transformation. In a number of plant species like Nicotinia tabacum 
Study of the Agrobacterium T-DNA fragments integrated into the transformed root genome: The relationship between different
Agrobacterium genes in the transformed root genome and the root growth capacity was studied. The variation of individual lines occurs because of the integration site of T-DNA into the nuclear genome of the host plant. We focused on the ags gene, located in the TR-DNA of pRiA4, which encodes a protein responsible for agropine biosynthesis in transformed cells [10a] . We also studied the rolC gene located in the T L -DNA of the plant genome, finding it to be present in all the tested root lines ( The presence of rol C, ags and SQS1 genes in the HRs genome was confirmed by PCR (Figure 4) . The transgenic root lines that gave two bands: at 196 bp corresponding to the SQS1 gene and at 534 bp to the rolC fragment from Agrobacterium strains were selected. The presence of the rolC and SQS1 genes was confirmed in 100% and 87.88% of the induced transformed root lines, respectively ( in the W. somnifera root cultures. Quantitative evaluation of root lines showed that THRs carrying the SQS1 gene contained 1.5-fold more WFA (330±0.87µg g -1 DW) than AHRs (218±0.17µg g -1 DW). Based on these results, the gene transformation strategy was developed and experimentally implemented to increase WFA accumulation in the HR cultures. As shown in Figure 5 , WFA contents in the A4 wild type HRs, untransformed W. somnifera normal roots and the aerial parts of in vitro plant seedlings were 196±0.12µg g -1 DW, 200±0.18µg g -1 DW and 275±0.54µg g -1 DW, respectively. These results suggest that SQS1 gene transformation effectively increases WFA production in W. somnifera THRs, which organize an ideal culture system for WTDs biosynthesis, in sterile conditions and without expensive phytohormones, as advocated by Kumar et al. [8h] . Agrobacterium strains and culture: The Agrobacterium tumefaciens strains C58C1 (pRiA4) or C58C1 (pRiA4) (pBIs SQS1) were used in all the experiments. A. tumefaciens C58C1 (pRiA4) has the same virulence and plasmid as A. rhizogenes A4, but has advantages over the wild type. It can be used to obtain wild type HRs and is also very easy to transform, hence it is presently used for metabolic engineering experiments [12a, 12b] . The Agrobacterium was grown at 28 ˚C in YEB medium ( Figure 6D) [12c].
Establishment and culture of W. somnifera hairy roots: Leaf sections (2-2.5 cm) of in vitro seedlings of W. somnifera were used for inoculation ( Figure 6E Genomic DNA isolation and PCR analysis: DNA was isolated from THR culture clones according to a previously described method [6d]. Polymerase chain reaction (PCR) was used to test the presence of the transferred rolC and SQS1 genes as in Moyano et al.
Production of withaferin A from transformed hairy root culture of W. somnifera Natural Product Communications Vol. 13 (8) 2018 947 [9d] and Mirjalili et al. [6c] . DNA from A. tumefaciens C58C1 (pRiA4) (pBIs) carrying the AtSQS1 gene and AHRs of in vitro plants served as the positive and the negative control, respectively. The amplified product was separated by 1.5% agarose gel electrophoresis in 1×TAE buffer (0.04 M Tris-acetate, 1 mM EDTA; pH=8.0) at 80 V for 60 min. The gel was subsequently stained with DNA green viewer, and was then photographed using a Transluminator (PBT-10, Vilberlourmat, France).
Extraction and analysis of withaferin A: 1 g of DW of the studied dry roots was ground into fine powder (about 1 mm), drenched in methanol (10 mL), and sonicated for 30 min. High-Performance Liquid Chromatography (HPLC) determination of WFA was conducted as described by Sivanandhan et al. [6a] . A KNAUER HPLC systems equipped with a quaternary K-1001pump and a K-2800 photodiode array detector operating at 250 nm were performed for the analysis. Separations were carried out with a reversed-phase C18 column (Eurospher, 25 cm × 4.6 mm, 5 µm particle) using an isocratic elution program with a mixture of methanol and water at the ratio of 65:35. The mobile phase flow rate was adjusted at 1 mL min -1 . WFA standard (> 95%) was purchased from Sigma (Sigma-Aldrich Corporation, MO, USA). A standard solution was prepared in pure methanol and then diluted to plot the standard curve in the range of concentrations (1-100 µg mL -1 ). Peak was monitored at 225 nm wavelength. The injection volume was 20 µL and the temperature was maintained at 25 ºC. The presence of WFA in the stock plants used in this study has been previously confirmed by LC-MS/MS technique [12e]. Methanol, HPLC grade methanol and phosphoric acid of analytical grade were prepared from Merck (Darmstadt, Germany). HPLC grade water was used during the analysis.
